Spectral Medical Inc. (TSE:EDT – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$0.79 and last traded at C$0.72, with a volume of 139480 shares trading hands. The stock had previously closed at C$0.75.
Spectral Medical Stock Down 2.7 %
The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. The business has a 50 day moving average of C$0.55 and a 200 day moving average of C$0.58. The firm has a market capitalization of C$205.31 million, a price-to-earnings ratio of -10.43 and a beta of 0.96.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Featured Articles
- Five stocks we like better than Spectral Medical
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- How to Invest in Small Cap Stocks
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Home Depot Turns a Corner: New Highs Likely This Year
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
